 Neurocrine Biosciences, Inc. NASDAQ:NBIX Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Director Matthew Abernethy - CFO Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Paul Matteis - Stifel, Nicolaus Company Brian Skorney - Robert W. Baird Co. Carter Gould - Barclays Bank Neena Bitritto-Garg - Citigroup Tazeen Ahmad - Bank of America Merrill Lynch Joshua Schimmer - Evercore ISI Anupam Rama - JPMorgan Chase Co. Charles Duncan - Cantor Fitzgerald Co. Philip Nadeau - Cowen and Company Jeff Hung - Morgan Stanley Chris Shibutani - Goldman Sachs Group Jay Olson - Oppenheimer Laura Chico - Wedbush Securities Marc Goodman - SVB Leerink Vamil Divan - Mizuho Securities Myles Minter - William Blair Company Yatin Suneja - Guggenheim Securities Operator Good day, everyone, and welcome to todays Neurocrine Biosciences Reports First Quarter Results. 